Larimar Therapeutics (LRMR) Cash from Investing Activities (QoQ) (2013 - 2025)
Larimar Therapeutics (LRMR) Cash from Investing Activities (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 30.41% |
| Mar 31, 2025 | -24.74% |
| Dec 31, 2024 | -29.61% |
| Sep 30, 2024 | 142.95% |
| Jun 30, 2024 | 7.13% |
| Mar 31, 2024 | -2,500.38% |
| Dec 31, 2023 | 94.34% |
| Sep 30, 2023 | -371.95% |
| Jun 30, 2023 | -110.66% |
| Mar 31, 2023 | 276.61% |
| Dec 31, 2022 | -1,443.56% |
| Dec 31, 2021 | 195.57% |
| Sep 30, 2021 | -135.33% |
| Jun 30, 2021 | 266.01% |
| Mar 31, 2021 | 122.30% |
| Dec 31, 2020 | -294,212.50% |
| Sep 30, 2020 | -100.02% |
| Jun 30, 2020 | 5,424.04% |
| Mar 31, 2020 | -1,456.00% |
| Jun 30, 2019 | -204.09% |